We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.8B
AUM Growth
-$159M
Cap. Flow
-$187M
Cap. Flow %
-3.89%
Top 10 Hldgs %
18.32%
Holding
695
New
64
Increased
242
Reduced
263
Closed
62

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$40.8M
2
INTU icon
Intuit
INTU
+$32.8M
3
META icon
Meta Platforms (Facebook)
META
+$30.3M
4
MA icon
Mastercard
MA
+$28.3M
5
NKE icon
Nike
NKE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 29.43%
2 Financials 13.37%
3 Technology 9.86%
4 Consumer Discretionary 7.77%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHK
151
DELISTED
Chesapeake Energy Corporation
CHK
$9.15M 0.19%
4,095
+1,954
+91% +$5.51M
J icon
152
Jacobs Solutions
J
$15.9B
$9.08M 0.19%
270,204
+86,923
+47% +$3.18M
MOS icon
153
The Mosaic Company
MOS
$7.09B
$8.98M 0.19%
191,760
+118,326
+161% +$5.37M
IP icon
154
International Paper
IP
$22.3B
$8.85M 0.18%
196,433
-45,616
-19% -$2.26M
ES icon
155
Eversource Energy
ES
$28.2B
$8.82M 0.18%
194,158
+188,314
+3,222% +$9.13M
RDUS
156
DELISTED
Radius Health, Inc.
RDUS
$8.8M 0.18%
130,000
-16,000
-11% -$745K
KMB icon
157
Kimberly-Clark
KMB
$36.4B
$8.75M 0.18%
82,578
-17,602
-18% -$1.92M
ORCL icon
158
Oracle
ORCL
$331B
$8.57M 0.18%
212,612
+19,280
+10% +$836K
PRE
159
DELISTED
PARTNERRE LTD
PRE
$8.55M 0.18%
66,538
+36,543
+122% +$4.71M
TW
160
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$8.5M 0.18%
67,543
-28,942
-30% -$3.88M
ELV icon
161
Elevance Health
ELV
$81.9B
$8.47M 0.18%
51,585
-32,209
-38% -$5.15M
LLY icon
162
Eli Lilly
LLY
$1.07T
$8.46M 0.18%
101,271
+3,526
+4% +$269K
KGC icon
163
Kinross Gold
KGC
$28.5B
$8.35M 0.17%
3,581,016
+1,176,972
+49% +$2.81M
CVS icon
164
CVS Health
CVS
$137B
$8.33M 0.17%
79,448
+19,786
+33% +$2.02M
SWK icon
165
Stanley Black & Decker
SWK
$14.2B
$8.2M 0.17%
77,902
+73,814
+1,806% +$7.52M
IBM icon
166
IBM
IBM
$202B
$8.11M 0.17%
52,159
+5,070
+11% +$815K
APC
167
DELISTED
Anadarko Petroleum
APC
$8.01M 0.17%
102,657
+18,546
+22% +$1.61M
CAH icon
168
Cardinal Health
CAH
$53.4B
$7.99M 0.17%
95,461
+10,127
+12% +$894K
AZO icon
169
AutoZone
AZO
$48.3B
$7.97M 0.17%
11,957
+10,598
+780% +$7.25M
ETR icon
170
Entergy
ETR
$54.1B
$7.87M 0.16%
223,308
+138,544
+163% +$5.2M
BAX icon
171
Baxter International
BAX
$11.6B
$7.78M 0.16%
202,782
+115,182
+131% +$4.31M
BBBY
172
DELISTED
Bed Bath & Beyond Inc
BBBY
$7.78M 0.16%
112,748
+93,864
+497% +$6.72M
UTHR icon
173
United Therapeutics
UTHR
$26.3B
$7.65M 0.16%
44,000
+8,000
+22% +$1.44M
BSX icon
174
Boston Scientific
BSX
$65.8B
$7.65M 0.16%
432,386
-831,266
-66% -$14.9M
MJN
175
DELISTED
Mead Johnson Nutrition Company
MJN
$7.6M 0.16%
84,281
-68,417
-45% -$6.6M

Similar funds

Candriam SCA's Q2 2015 Portfolio in Review

As of Q2 2015, Candriam SCA held 695 positions worth $4.8B, down 3.2% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $187M in Q2 2015, closing 62 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Japan ETF, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in American Airlines Group worth $11.6M.

  • Candriam SCA's largest Q2 2015 buy was American Airlines Group: 290,014 shares worth $11.6M.
  • Candriam SCA added most to Alphabet (Google) Class C in Q2 2015, an estimated $33.8M increase.
  • Candriam SCA's biggest Q2 2015 reduction was Intuit, cutting an estimated $32.8M.
  • Candriam SCA fully exited iShares MSCI Japan ETF in Q2 2015, selling an estimated $40.8M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.8B portfolio in Q2 2015.
  • Candriam SCA opened 64 new positions and closed 62 in Q2 2015.
  • Candriam SCA's portfolio value fell 3.2% quarter-over-quarter to $4.8B.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.